BayBG in €6m AMW round

KfW, IBG Beteiligungsgesellschaft Sachsen-Anhalt and UnternehmerTUM Venture Capital also reinvested. They were joined by new backer Wachstumsfonds Bayern.

The capital will be used for the development of new products and the company's expansion. AMW aims to grow its existing sites in Bavaria and Saxony-Anhalt, and recently acquired an additional site in order to build a new production facility. The business claims its staff doubled in the last 12 months to 64.

Previous funding
In September 2014, BayBG invested in AMW's second closing of its €5m series-A round. The venture capital firm invested €3.6m alongside UnternehmerTUM Fund and IBG's second fund. Bayern Kapital, KfW and AMW managing director Wilfried Fischer invested €1.4m in the round's first close, led by SHS.

Company
Founded in 2008 and based in Warngau, AMW is a pharmaceutical company specialising in drug delivery systems. The products, designed to treat cancer and nervous system disorders, deliver medication to patients via patches and implants. These treatments release drugs in a controlled manner adapted to the needs of patients.

People
BayBG Bayerische Beteiligungsgesellschaft – Otto Hopfner (investment manager).
AMW – Wilfried Fischer (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Healthcare
• Germany
• Bayerische Beteiligungsgesellschaft mbH (BayBG)
• Venture